DIGITAL medication management company, MedAdvisor, is targeting growth in the US through a three-year strategic alliance agreement with payment and population health management provider, HMS.
The deal will enable a deep connection between HMS' health engagement solution, Eliza, and MedAdvisor's health programs to enable healthcare organisations including insurance companies to communicate proactively and deliver messages to patients, to improve overall health outcomes.
MedAdvisor CEO, Robert Read, said the alliance would generate new opportunities for the business, with the company forecasting a strong market appetite for its services, which "over time could represent a significant portion of the existing outreach volume".
"This deal opens up a new addressable patient population beyond our existing partnerships," he said.
"It also adds the potential to bring a different sponsor for our health programs, in the US health insurer [market], while leveraging the same MedAdvisor global technology platform.
"HMS has a significant pipeline of opportunities to work collaboratively in the US and Australia and we look forward to working with them under our new strategic alliance agreement."
MedAdvisor Chief Revenue Officer, Steve Watt, said the alliance "will help accelerate revenue growth and customer acquisition", with the deal extending MedAdvisor's reach in the US beyond pharmacies and pharmaceutical companies to include insurance companies and payors.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jul 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jul 20
